Jianmin Pharmaceutical GroupLtd Management
Management criteria checks 3/4
Jianmin Pharmaceutical GroupLtd's CEO is Jun Wang, appointed in Sep 2022, has a tenure of 2.33 years. directly owns 0.23% of the company’s shares, worth CN¥14.18M. The average tenure of the management team and the board of directors is 2.3 years and 2.3 years respectively.
Key information
Jun Wang
Chief executive officer
CN¥891.4k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 2.3yrs |
| CEO ownership | 0.2% |
| Management average tenure | 2.3yrs |
| Board average tenure | 2.3yrs |
Recent management updates
Recent updates
CEO
Jun Wang (47 yo)
2.3yrs
Tenure
CN¥891,400
Compensation
Mr. Jun Wang was Vice President of KPC Pharmaceuticals,Inc until September 08, 2020. He is Managing Director of Jianmin Pharmaceutical Group Co.,Ltd. He is Director and President of Jianmin Pharmaceutical...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 2.3yrs | CN¥891.40k | 0.23% CN¥ 14.2m | |
| Financial Director | 2.3yrs | CN¥511.20k | 0.055% CN¥ 3.5m | |
| VP & Director | 1.5yrs | CN¥210.40k | no data | |
| Secretary | 2.3yrs | CN¥408.80k | 0.024% CN¥ 1.5m | |
| Vice President | 2.3yrs | CN¥540.00k | 0.12% CN¥ 7.5m | |
| Vice President | 2.3yrs | CN¥540.00k | 0.11% CN¥ 6.6m |
2.3yrs
Average Tenure
49yo
Average Age
Experienced Management: 600976's management team is considered experienced (2.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 2.3yrs | CN¥891.40k | 0.23% CN¥ 14.2m | |
| VP & Director | 1.5yrs | CN¥210.40k | no data | |
| Chairman | 2.3yrs | CN¥2.10m | 0.27% CN¥ 16.8m | |
| Chairman of the Supervisory Board | 2.3yrs | no data | no data | |
| Independent Director | 2.3yrs | CN¥90.00k | no data | |
| Director | 2.3yrs | CN¥60.00k | no data | |
| Director | 2.3yrs | CN¥60.00k | no data | |
| Independent Director | 2.3yrs | CN¥90.00k | no data | |
| Supervisor | 2.3yrs | no data | no data | |
| Supervisor | 2.3yrs | no data | no data | |
| Supervisor | 2.3yrs | no data | no data | |
| Independent Director | 2.3yrs | CN¥90.00k | no data |
2.3yrs
Average Tenure
53.5yo
Average Age
Experienced Board: 600976's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/08 22:56 |
| End of Day Share Price | 2025/01/08 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Jianmin Pharmaceutical Group Co.,Ltd. is covered by 8 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shuchang Liu | Changjiang Securities Co. LTD. |
| Jing Qiang | China International Capital Corporation Limited |
| Xiaoyu Qian | Huatai United Securities Co., Ltd. |